MUCOSAL POLYAMINE METABOLISM IN THE COLUMNAR LINED ESOPHAGUS

被引:16
作者
GRAY, MR
WALLACE, HM
GOULDING, H
HOFFMAN, J
KENYON, WE
KINGSNORTH, AN
机构
[1] UNIV LIVERPOOL,DEPT SURG,LIVERPOOL L69 3BX,ENGLAND
[2] BROADGREEN HOSP,DEPT HISTOPATHOL,LIVERPOOL L14 3LB,MERSEYSIDE,ENGLAND
[3] UNIV ABERDEEN,DEPT MED & THERAPEUT & BIOMED SCI,ABERDEEN AB9 1FX,SCOTLAND
关键词
D O I
10.1136/gut.34.5.584
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mucosal ornithine decarboxylase activity and polyamine content has been proposed as a Possible marker for malignant potential in gastrointestinal mucosa. Polyamine content and histological findings were examined in 107 pairs of endoscopic biopsy specimens taken from gastric fundus, fundic and specialised Barrett's oesophagus and Barrett's adenocarcinoma. The content of putrescine (median nmol/mg protein, range) the primary product of ornithine decarboxylase showed a progressive increase from gastric fundus (0.41, 0.15-1-5); fundic (0.45, 0.01-4.08); specialised Barrett's oesophagus (0-54, 0.01-2.0); dysplastic columnar lined oesophagus (0.56, 0.31-3.1) to adenocarcinoma (1.23, 0.29-8.98). Adenocarcinoma putrescine content was significantly greater than gastric fundus (p<0.018) and fundic (p<0.03). Mucosal spermine, spermidine, and total polyamine values were greater in gastric fundus than fundic, specialised Barrett's oesophagus, and dysplastic columnar lined oesophagus (all p<0.001) suggesting failure to further metabolise putrescine to its higher polyamines in the metaplastic epithelium. Although metaplastic columnar lined oesophagus shows significant differences in polyamine metabolic activity from the stomach the important distinction between specialised and dysplastic columnar lined oesophagus cannot be made by measuring the polyamine content.
引用
收藏
页码:584 / 587
页数:4
相关论文
共 32 条
[1]  
BARDOCZ S, 1991, POLYAMINES GASTROINT
[2]  
BARRANCO SC, 1986, INVEST NEW DRUG, V4, P347
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   CLINICAL-CHEMISTRY OF POLYAMINES [J].
CHAYEN, R .
CELL BIOCHEMISTRY AND FUNCTION, 1984, 2 (01) :15-20
[5]  
DAMANI A, 1965, J MOL BIOL, V11, P438
[6]   BARRETTS-ESOPHAGUS [J].
DENT, J ;
BREMNER, CG ;
COLLEN, MJ ;
HAGGITT, RC ;
SPECHLER, SJ .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1991, 6 (01) :1-22
[7]  
GAREWAL H S, 1991, Gastroenterology, V100, pA364
[8]  
GAREWAL HS, 1988, CANCER RES, V48, P3288
[9]   INCREASE IN ORNITHINE DECARBOXYLASE ACTIVITY ASSOCIATED WITH DEVELOPMENT OF DYSPLASIA IN BARRETT ESOPHAGUS [J].
GAREWAL, HS ;
SAMPLINER, R ;
ALBERTS, D ;
STEINBRONN, K .
DIGESTIVE DISEASES AND SCIENCES, 1989, 34 (02) :312-314
[10]   ORNITHINE DECARBOXYLASE ACTIVITY IN BARRETTS ESOPHAGUS - A POTENTIAL MARKER FOR DYSPLASIA [J].
GAREWAL, HS ;
SAMPLINER, R ;
GERNER, E ;
STEINBRONN, K ;
ALBERTS, D ;
KENDALL, D .
GASTROENTEROLOGY, 1988, 94 (03) :819-821